E. Ercikan-Abali

发表

Active site-directed double mutants of dihydrofolate reductase.

M. Waltham, E. Ercikan-Abali, S. Mineishi, 1996, Cancer research.

Dihydrofolate reductase protein inhibits its own translation by binding to dihydrofolate reductase mRNA sequences within the coding region.

M. Waltham, E. Ercikan-Abali, D. Banerjee, 1997, Biochemistry.

Gene therapy for endometrial carcinoma with the herpes simplex thymidine kinase gene.

R. Barakat, E. Ercikan-Abali, D. Banerjee, 2000, Gynecologic oncology.

Protection of Marrow from Methotrexate Toxicity by Gene Transfer of Mutant Forms of Dihydrofolate Reductase into Hematopoietic Progenitor Cells

E. Ercikan-Abali, S. Mineishi, D. Banerjee, 1998 .

Use of variants of dihydrofolate reductase in gene transfer to produce resistance to methotrexate and trimetrexate.

E. Ercikan-Abali, S. Mineishi, D. Banerjee, 1999, Progress in experimental tumor research.

Protection of bone marrow cells from toxicity of chemotherapeutic agents targeted toward thymidylate synthase by transfer of mutant forms of human thymidylate synthase cDNA.

E. Ercikan-Abali, Y. Tong, J. Bertino, 1999, Progress in experimental tumor research.

Probing the Folate-binding Site of Human Thymidylate Synthase by Site-directed Mutagenesis

F. Maley, E. Ercikan-Abali, D. Banerjee, 1998, The Journal of Biological Chemistry.

Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line.

E. Ercikan-Abali, D. Banerjee, J. Bertino, 1996, Journal of the National Cancer Institute.

Molecular mechanisms of resistance to antifolates, a review.

M. Waltham, E. Ercikan-Abali, D. Banerjee, 1995, Acta biochimica Polonica.

Isolation and Characterization of Thymitaq (AG337) and 5-Fluoro-2-deoxyuridylate-resistant Mutants of Human Thymidylate Synthase from Ethyl Methanesulfonate-exposed Human Sarcoma HT1080 Cells*

E. Ercikan-Abali, D. Banerjee, J. Bertino, 1998, The Journal of Biological Chemistry.

mTOR inhibition leads to increased sensitivity to methotrexate

E. Ercikan-Abali, J. Bertino, G. Saydam, 2005 .

2,4-Diamino-5-substituted-quinazolines as inhibitors of a human dihydrofolate reductase with a site-directed mutation at position 22 and of the dihydrofolate reductases from Pneumocystis carinii and Toxoplasma gondii.

M. Waltham, E. Ercikan-Abali, J. Bertino, 1995, Journal of medicinal chemistry.

Variants of human dihydrofolate reductase with substitutions at leucine-22: effect on catalytic and inhibitor binding properties.

M. Waltham, E. Ercikan-Abali, D. Banerjee, 1996, Molecular pharmacology.

Active site-directed double mutants of dihydrofolate reductase.

M. Waltham, E. Ercikan-Abali, S. Nakahara, 1996, Cancer research.